Skip to content

Glove stocking study for Decetaxel -induced peripheral neuropathy

Exploratory clinical study on the prevention effect of Docetaxel-induced peripheral neuropathy by compression therapy using surgical gloves and lower limb stockings - Glove stocking study for Decetaxel -induced peripheral neuropathy

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs062200061
Enrollment
75
Registered
2021-03-11
Start date
2021-04-06
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer prostate cancer peripheral neuropathy

Interventions

Double the size of surgical gloves one size smaller than the appropriate size (eg, if 6 inches is the appropriate size, wear 5.5 inches) and wear it 30 minutes before docetaxel administration, and 30

Sponsors

Kato Takuma
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Prostate cancer patients to whom docetaxel / prednin therapy is introduced 2) Patients who are over 20 years old and have given their written consent 3) Hand size patients within the size range of commercially available surgical gloves. 4) Protect X Intense pressure support (ML size; height less than 178cm, calf circumference less than 44cm, thigh circumference less than 52cm, foot size 25 to 28cm), Protect X Intense pressure support (L-LL size; height more than 175cm calf Patients who can wear around 42cm to 52cm around the thigh, around 50 to 62cm around the thigh and 27 to 30cm of foot size)

Exclusion criteria

Exclusion criteria: 1) Patients with peripheral neuropathy at the start of the study 2) Patients who have received medications that may cause peripheral neuropathy in the past. 3) Patients with extremely small or large hands that fall outside the size range of commercially available surgical gloves. 4) Patients with extreme finger and leg deformities 5) Patients with acute deep vein thrombosis 6) Patients with thrombophlebitis of the superficial vein of lower limb 7) Patients with arterial circulation disorders such as obstructive arteriosclerosis, congestive heart failure, inflammatory or purulent diseases of lower limbs, and acute wounds 8) Patients with necrosis / gangrene, severe edema, purulent skin disease after skin transplantation 9) Diabetic patients with peripheral neuropathy 10) Patient whose ankle circumference exceeds 27cm 11) Other patients judged by the investigator to be inappropriate

Design outcomes

Primary

MeasureTime frame
peripheral neuropathy

Secondary

MeasureTime frame
Changes in the claw

Contacts

Public ContactTakuma Kato

Kagawa university hospital

t.katou.uro@gmail.com+81-87-898-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026